Literature DB >> 4369214

Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).

R J Miller, L L Iversen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4369214     DOI： 10.1007/bf00499035

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  7 in total

1.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

2.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

3.  The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  The effect of trivastal, haloperidol and dibutyryl cyclic AMP on (14C)dopamine synthesis in rat striatum.

Authors:  M Goldstein; B Anagnoste; C Shirron
Journal:  J Pharm Pharmacol       Date:  1973-04       Impact factor: 3.765

5.  Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent.

Authors:  P Jenner; A R Taylor; D B Campbell
Journal:  J Pharm Pharmacol       Date:  1973-09       Impact factor: 3.765

6.  Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina.

Authors:  J H Brown; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

7.  [Action of various pharmacologic reagents on the stereotyped movements induced in rats by injection of 1-(2"-pyrimidyl)-4-piperonyl piperazine (piribedil)].

Authors:  J C Poignant; M Laubie; D Tsoucaris-Kupfer; H Schmitt
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1972-07-31
  7 in total
  11 in total

1.  Proceedings: Effect of aporphine alkaloids on central dopamine receptors.

Authors:  P H Kelly; R J Miller; J L Neumeyer
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Solid-phase extraction of piribedil and its metabolites from plasma and urine without and after deconjugation, by high performance liquid chromatography.

Authors:  S Sarati; S Caccia
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

3.  L-Dopa and piribedil alter different components of attentional behavior dependent on dose.

Authors:  M Cheal
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  The effects of dopamine, piribedil (ET-495) and its metabolite S-584 on retinal adenylate cyclase.

Authors:  M Schorderet
Journal:  Experientia       Date:  1975-11-15

Review 5.  Parkinson's disease: pathological mechanisms and actions of piribedil.

Authors:  P Jenner
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

6.  Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.

Authors:  G M Anlezark; B S Meldrum
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

7.  Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.

Authors:  P Protais; J Costentin; J C Schwartz
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

8.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  3,4-disubstituted phenyliminoimidazolidines as potential prodrugs of the purported dopamine agonist 3,4-dihydroxyphenylimino-2-imidazolidine (DPI).

Authors:  H A Houwing; J C van Oene; A S Horn
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

10.  Kinetics of piribedil and effects on dopamine metabolism: hepatic biotransformation is not a determinant of its dopaminergic action in rats.

Authors:  S Sarati; G Guiso; S Garattini; S Caccia
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.